Solara Active Pharma Sciences Limited reported earnings results for the fourth quarter and full year ended March 31, 2022. For the fourth quarter, the company reported sales was INR 3,608.2 million compared to INR 4,442.1 million a year ago. Revenue was INR 3,668.9 million compared to INR 4,539.9 million a year ago. Net income was INR 18.8 million compared to INR 566.5 million a year ago. Basic earnings per share from continuing operations was INR 0.53 compared to INR 15.57 a year ago. Diluted earnings per share from continuing operations was INR 0.53 compared to INR 15.24 a year ago.
For the full year, sales was INR 12,683.4 million compared to INR 16,168.8 million a year ago. Revenue was INR 12,883.6 million compared to INR 16,456.5 million a year ago. Net loss was INR 581.5 million compared to net income of INR 2,214 million a year ago. Basic loss per share from continuing operations was INR 16.18 compared to basic earnings per share from continuing operations of INR 69 a year ago. Diluted loss per share from continuing operations was INR 16.18 compared to diluted earnings per share from continuing operations of INR 64.52 a year ago.